Meibang Shares Plans to Increase Capital by 80 Million Yuan and Establish Hong Kong Subsidiary

Corporate Action
โดย CLS·CN·Read original
Summary · why it matters

Meibang Shares announced that its board of directors has approved a proposal to increase capital in its wholly-owned subsidiary Shaanxi Nuozheng Biotechnology Co., Ltd. by 80 million yuan, and to invest in establishing a wholly-owned Hong Kong subsidiary with registered capital of 500,000 Hong Kong dollars, with the company holding 100% equity.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews